Related Experiment Video

Updated: Jul 17, 2026

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs
08:13

Rapid Quantification of Mitogen-induced Blastogenesis in T Lymphocytes for Identifying Immunomodulatory Drugs

Published on: December 27, 2016

[Effect of extracellular-signal regulated kinase 1/2 specific repressor PD98059 on murine lymphocyte proliferation]

Zhen-ping Teng1, Fei-yue Xing, Tong Wang

  • 1Center for Tissue Transplantation and Immunology, College of Life Science and Techology, Jinan University, Guangzhou 510632, China.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology
|February 9, 2007
PubMed
Abstract

Insights

PD98059, an inhibitor of extracellular signal regulated kinase 1/2 (ERK1/2) signaling, significantly inhibits murine lymphocyte proliferation. This compound blocks lymphocyte cell cycle progression at S and G2/M phases, highlighting ERK1/2

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Lymphocyte proliferation is crucial for adaptive immunity.
  • Extracellular signal regulated kinase 1/2 (ERK1/2) signaling pathways regulate cell growth and differentiation.
  • Understanding the role of ERK1/2 in lymphocyte proliferation is key to developing immunomodulatory therapies.

Purpose of the Study:

  • To investigate the impact of PD98059, a specific ERK1/2 inhibitor, on murine lymphocyte proliferation.
  • To elucidate the effects of PD98059 on lymphocyte cell cycle progression.

Main Methods:

  • Murine lymphocytes were isolated and stained with CFDA-SE.
  • Cells were stimulated with polyclonal activators: concanavalin A (ConA) or phorbol 12,13-dibutyrate (PDB) plus ionomycin (Ion).
  • Proliferation and cell cycle distribution were analyzed by flow cytometry (FCM).

Main Results:

  • PD98059 demonstrated a dose-dependent inhibition of ConA-induced lymphocyte proliferation.
  • The inhibitor caused a significant block in the S and G2/M phases of the cell cycle.
  • Similar effects were observed with PDB plus ionomycin stimulation, with more distinct S and G2/M phase arrests.

Conclusions:

  • PD98059 effectively inhibits murine lymphocyte proliferation.
  • The ERK1/2 signaling pathway is critical for lymphocyte proliferation.
  • Inhibition of ERK1/2 signaling arrests lymphocytes in the S and G2/M phases, impacting cell cycle progression.

More Related Videos

Isolation and Activation of Murine Lymphocytes08:08

Isolation and Activation of Murine Lymphocytes

Published on: October 30, 2016

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...